Trials / Completed
CompletedNCT04031222
Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes
Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for Diabetes (MI4D)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- The Hospital for Sick Children · Academic / Other
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.
Detailed description
This study proposes to characterize inflammatory biomarkers, insulin resistance and fecal microbiome composition in obese/pre-diabetic adolescents after glucose ingestion, followed by an oral fat tolerance test on a separate visit. Lipoprotein abnormalities and intestinal biomarkers, post-lipid ingestion, will also be evaluated. The primary aim is to assess the role of inflammation in insulin resistant conditions (i.e., obesity and pre-diabetes) and the subsequent development of disease, such as type 2 diabetes (T2D) and cardiovascular disease (CVD), in the adolescent population.
Conditions
- Obesity
- PreDiabetes
- Adolescent Obesity
- Inflammation
- Metabolic Problems
- Insulin Resistance
- Gut Microbiome
- Immunity
- Beta Cell Dysfunction
- Gut Hormones
Timeline
- Start date
- 2017-05-19
- Primary completion
- 2019-02-15
- Completion
- 2019-03-01
- First posted
- 2019-07-24
- Last updated
- 2022-09-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04031222. Inclusion in this directory is not an endorsement.